ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

gedeon richter plc. - ulipristalio acetatas - leiomyoma - lytiniai hormonai ir moduliatoriai lytinių organų sistemos, - ulipristal acetatas yra nurodyta už vieną gydymo kursą, priešoperacinis gydymas, vidutinio sunkumo ir sunkių simptomų gimdos fibroma suaugusiųjų vaisingo amžiaus moterys. ulipristal acetatas yra nurodyta su pertrūkiais gydant vidutinio sunkumo ir sunkių simptomų gimdos fibroma suaugusiųjų vaisingo amžiaus moterų, kurie nėra tinkami chirurgija.

লিত্ভা - লিথুয়েনীয় - SMCA (Valstybinė vaistų kontrolės tarnyba)

fresenius kabi polska sp.z.o.o. - natrio chloridas/natrio acetatas trihidratas/kalio chloridas/kalcio chloridas dihidratas/magnio chloridas heksahidratas - infuzinis tirpalas - 5,9 g/4,15 g/0,3 g/0,288 g/0,2 g/1000 ml - electrolytes

লিত্ভা - লিথুয়েনীয় - SMCA (Valstybinė vaistų kontrolės tarnyba)

sandoz d.d. - ulipristalio acetatas - plėvele dengta tabletė - 30 mg - ulipristal

লিত্ভা - লিথুয়েনীয় - SMCA (Valstybinė vaistų kontrolės tarnyba)

baxter healthcare ltd. - natrio chloridas/kalio chloridas/kalcio chloridas dihidratas/natrio laktatas - infuzinis tirpalas - 6 g/0,4 g/0,27 g/3,2 g/1000 ml - electrolytes

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatos navikai, kastracija-atsparus - antinavikiniai vaistai - treatment of adult patients with prostate cancer.

লিত্ভা - লিথুয়েনীয় - SMCA (Valstybinė vaistų kontrolės tarnyba)

zentiva k.s. - glatiramerio acetatas - injekcinis tirpalas užpildytame švirkšte - 20 mg/ml - glatiramer acetate

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

mylan ireland limited - abiraterono acetatas - prostatos navikai - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - prostatos navikai - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimycotics sisteminiam vartojimui - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

dechra regulatory b.v. - betamethasone acetate, terbinafine, florfenicol - kortikosteroidai ir antiinfectives kartu - Šunys - Ūminio ausies uždegimo gydymas.